Eric Schadt - President & Chief R&D Officer, Director at GeneDx Holdings Corp.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & Chief R&D Officer, Director
Stock Symbol
WGS, WGSWW on Nasdaq
Industry
Services-Health Services
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Eric Schadt since 7/7/2023

Holdings reported by Eric Schadt for GeneDx Holdings Corp.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 1,024,563 $2.64 M $2.58 Apr 25, 2022 Direct Class A Common Stock
Class A Common Stock 243,380 $789 K $3.24 May 20, 2022 Direct
Employee Stock Option (Right to Buy) 635,368 Apr 4, 2022 Direct Class A Common Stock

Transactions reported by Eric Schadt for GeneDx Holdings Corp.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership